Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer

BACKGROUND: Sarcopenia is commonly observed in patients with advanced‐stage epithelial ovarian cancer (EOC). However, the effect of body composition changes—during primary debulking surgery (PDS) and adjuvant platinum‐based chemotherapy—on outcomes of patients with advanced‐stage EOC is unknown. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chueh‐Yi, Yang, Yuh‐Cheng, Chen, Tze‐Chien, Chen, Jen‐Ruei, Chen, Yu‐Jen, Wu, Meng‐Hao, Jan, Ya‐Ting, Chang, Chih‐Long, Lee, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113537/
https://www.ncbi.nlm.nih.gov/pubmed/31999069
http://dx.doi.org/10.1002/jcsm.12524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113537/
https://www.ncbi.nlm.nih.gov/pubmed/31999069
http://dx.doi.org/10.1002/jcsm.12524

Ejemplares similares